phosphorodichloridic acid pentyl ester | 6188-71-2

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 有机磷酸及其衍生物
• 英文名称: phosphorodichloridic acid pentyl ester
• 英文别名: Phosphorodichloridic acid, pentyl ester；1-dichlorophosphoryloxypentane
• CAS: 6188-71-2
• 化学式: C₅H₁₁Cl₂O₂P
• 分子量: 205.021
• InChiKey: XBDKTZIPGXWWJH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  10
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  phosphorodichloridic acid pentyl ester 在 sodium fluoride 作用下， 生成 phosphorodifluoridic acid pentyl ester
  参考文献：
  名称：

  Voigt,D. et al., Bulletin de la Societe Chimique de France, 1969, p. 3383 - 3386

  摘要：

  DOI：
• 作为产物：
  描述：

  戊醇 在 三乙胺 、 三氯氧磷 作用下， 以 氯仿 为溶剂， 反应 2.0h， 生成 phosphorodichloridic acid pentyl ester
  参考文献：
  名称：

  Synthesis of structural analogues of hexadecylphosphocholine and their antineoplastic, antimicrobial and amoebicidal activity

  摘要：

  Twelve derivatives of hexadecylphosphocholine (miltefosine) were synthesized to determine how the position and length of the alkyl chain within the molecule influence their biological activities. The prepared alkylphosphocholines have the same molecular formula as miltefosine. Activity of the compounds was studied against a spectrum of tumour cells, two species of protozoans, bacteria and yeast. Antitumour efficacy of some alkylphosphocholines measured up on MCF-7, A2780, HUT-78 and THP-1 cell lines was higher than that of miltefosine. The compounds showed antiprotozoal activity against Acanthamoeba lugdunensis and Acanthamoeba quina. Some of them also possess fungicidal activity against Candida albicans equal to miltefosine. No antibacterial activity was observed against Staphylococcus aureus and Escherichia coil. A difference in position of a long hydrocarbon chain within the structure with maximum efficacy was observed for antitumour, antiprotozoal and antifungal activity. (C) 2015 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2015.02.014

文献信息

• [EN] CHOLESTEROL/BILE ACID/BILE ACID DERIVATIVE-MODIFIED THERAPEUTIC ANTI-CANCER DRUGS<br/>[FR] MEDICAMENTS ANTICANCEREUX THERAPEUTIQUES MODIFIES PAR LE CHOLESTEROL/L'ACIDE BILIAIRE/LES DERIVES D'ACIDE BILIAIRE
  申请人：SONUS PHARMA INC

  公开号：WO2005118612A1

  公开（公告）日：2005-12-15

  Cholesterol-modified anti-cancer therapeutic drug compounds, bile-acid-modified anti-cancer therapeutic drug compounds, and bile-acid-derivative-modified anti-cancer therapeutic drug compounds; emulsion, microemulsion, and micelle formulations that include the compounds, methods for administering the compounds and formulations; and methods for treating cancer using the compounds and formulations.

  胆固醇修饰的抗癌治疗药物化合物，胆酸修饰的抗癌治疗药物化合物，以及胆酸衍生物修饰的抗癌治疗药物化合物；包括这些化合物的乳剂、微乳剂和胶束配方，用于给药这些化合物和配方的方法；以及使用这些化合物和配方治疗癌症的方法。
• LIPOPHILIC ANTICANCER DRUG COMPOUNDS, COMPOSITIONS AND RELATED METHODS
  申请人：Zhang Yuehua

  公开号：US20070142331A1

  公开（公告）日：2007-06-21

  Lipophilic anticancer drug compounds, compositions that include the compounds, and methods for treating a cell proliferative disease using the compounds.

  亲脂性抗癌药物化合物，包括该化合物的组合物，以及使用该化合物治疗细胞增殖性疾病的方法。
• Synthesis of Chlorothioformates from Xanthates
  作者：Christopher Abelt、Megan Fikse、William Bylund、Nicolas Holubowitch

  DOI：10.1055/s-2006-950356

  日期：——

  The Vilsmeier reagent derived from N-formylmorpholine produces chlorothioformates from primary and secondary alkyl xanthates. The major side products are the corresponding alkyl chlorides. Secondary alkyl chlorothioformates give lower yields due to their instability. Treating xanthates with other common chlorinating agents (oxalyl chloride, thionyl chloride) gives only dialkyl thiodicarbonates.

  由N-甲酰基吗啉衍生的Vilsmeier试剂能从一烷基和二烷基黄原酸盐生成氯硫碳酸酯，主要副产品是相应的烷基氯。二烷基氯硫碳酸酯产率较低，因其不稳定性所致。用其他常见氯化剂（草酰氯、亚硫酰氯）处理黄原酸盐只能得到二烷基硫代碳酸酯。
• LIPOPHILIC DI(ANTICANCER DRUG) COMPOUNDS, COMPOSITIONS, AND RELATED METHODS
  申请人：Zhang Yuehua

  公开号：US20070141093A1

  公开（公告）日：2007-06-21

  Lipophilic di(anticancer drug) compounds, compositions that include the compounds, and methods for treating a cell proliferative disease using the compounds.

  亲脂性双(抗癌药物)化合物，包括这些化合物的组合物，以及使用这些化合物治疗细胞增殖性疾病的方法。
• CROSS-LINKABLE FLAME RETARDANT MATERIALS
  申请人：International Business Machines Corporation

  公开号：US20180163139A1

  公开（公告）日：2018-06-14

  A cross-linkable flame retardant material includes a terminal furan-containing flame retardant moiety. The terminal furan-containing flame retardant moiety includes a furan moiety bonded to a phosphorus moiety via a phosphoryl linkage or via a phosphinyl linkage.

  一种可交联的阻燃材料包括一个含有末端呋喃基阻燃基团的材料。该含有末端呋喃基阻燃基团包括通过磷酰键或磷酰基键与磷基团结合的呋喃基团。